CME Group Inc. (NASDAQ:CME – Get Free Report)’s stock price hit a new 52-week high on Thursday after Bank of America raised their price target on the stock from $200.00 to $219.00. Bank of America currently has an underperform rating on the stock. CME Group traded as high as $271.22 and last traded at $270.10, with a volume of 1462780 shares. The stock had previously closed at $262.54.
Several other research analysts also recently commented on CME. Raymond James raised CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target on the stock in a research report on Monday, March 10th. Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and cut their target price for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Barclays raised their price target on shares of CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Oppenheimer boosted their price objective on shares of CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a report on Thursday, February 13th. Finally, Erste Group Bank upgraded shares of CME Group to a “strong-buy” rating in a research note on Monday, March 17th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus price target of $241.53.
Get Our Latest Research Report on CME
Insider Transactions at CME Group
Hedge Funds Weigh In On CME Group
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. SJS Investment Consulting Inc. raised its position in shares of CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after buying an additional 97 shares in the last quarter. Dunhill Financial LLC boosted its stake in shares of CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares in the last quarter. New Age Alpha Advisors LLC grew its holdings in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 43 shares during the last quarter. Financial Life Planners acquired a new position in CME Group during the 4th quarter worth approximately $32,000. Finally, Knuff & Co LLC bought a new position in CME Group in the 4th quarter valued at approximately $33,000. 87.75% of the stock is owned by institutional investors and hedge funds.
CME Group Price Performance
The business’s 50-day simple moving average is $251.50 and its two-hundred day simple moving average is $236.71. The stock has a market cap of $97.53 billion, a price-to-earnings ratio of 27.99, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.
CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.85%. The ex-dividend date of this dividend was Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is 51.71%.
CME Group declared that its Board of Directors has initiated a stock buyback plan on Thursday, December 5th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s board believes its stock is undervalued.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Ride Out The Recession With These Dividend Kings
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
- What is the FTSE 100 index?
- Big Buybacks: 3 Large Caps Exceed 5% Repurchase Power
- Low PE Growth Stocks: Unlocking Investment Opportunities
- NVIDIA vs Qualcomm: Which Is the Better Buy for Q2?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.